Schedules of Controlled Substances: Placement of Bromazolam in Schedule I; Correction
On March 16, 2026, the Drug Enforcement Administration published a temporary order placing 8-bromo-1-methyl-6-phenyl-4H- benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine (commonly k...
Drug Enforcement Administration, Department of Justice.
ACTION:
Correcting amendment.
SUMMARY:
On March 16, 2026, the Drug Enforcement Administration published a temporary order placing 8-bromo-1-methyl-6-phenyl-4
H
-benzo[
f][1,2,4]triazolo[4,3-
a][1,4]diazepine (commonly known as bromazolam), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers are possible, in schedule I of the Controlled Substances Act. DEA published this temporary order that included an invalid chemical name for bromazolam. This document corrects that error, adding the valid chemical name for bromazolam.
DATES:
This correcting amendment is effective June 24, 2026, and applicable beginning March 16, 2026.
FOR FURTHER INFORMATION CONTACT:
Dr. Terrence L. Boos, Drug and Chemical Evaluation Section, Diversion Control Division, Drug Enforcement Administration; Telephone: (571) 362-3249.
( printed page 37822)
SUPPLEMENTARY INFORMATION:
The placement of bromazolam under schedule I was effective on March 16, 2026.[1]
After publication of the temporary scheduling order, DEA included an invalid chemical name for bromazolam as 8-bromo-1-methyl-6-phenyl-4
H
-benzo[
f][1,2,4]triazolo[4,3-
a][l, 4]diazepine. This document corrects the chemical name for bromazolam as 8-bromo-1-methyl-6-phenyl-4
H
-benzo[
f][1,2,4]triazolo[4,3-
a][1,4]diazepine.
(86) 8-bromo-1-methyl-6-phenyl-4
H
-benzo[
f][1,2,4]triazolo[4,3-
a][1,4]diazepine, its salts, isomers, and salts of isomers (Other name: bromazolam)
2778
* * * * * * *
Signing Authority
This document of the Drug Enforcement Administration was signed on June 16, 2026, by DEA Administrator Terrance C. Cole. That document with the original signature and date is maintained by DEA. For administrative purposes only, and in compliance with requirements of the Office of the Federal Register, the undersigned DEA Federal Register Liaison Officer has been authorized to sign and submit the document in electronic format for publication, as an official document of DEA. This administrative process in no way alters the legal effect of this document upon publication in the
Federal Register
.
Heather Achbach,
Federal Register Liaison Officer, Drug Enforcement Administration.
Footnotes
1.
Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I, 91 FR 12504 (Mar. 16, 2026).